Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 1:49 PM
Ignite Modification Date:
2025-12-25 @ 12:42 PM
NCT ID:
NCT05665595
Group ID:
EG000
Title:
Pembrolizumab/Vibostolimab
Description:
Participants received pembrolizumab/vibostolimab (coformulation of 200 mg pembrolizumab and 200 mg vibostolimab) via intravenous (IV) infusion on Day 1 of each cycle (cycle length = 3 weeks) for up to 17 cycles (up to \~1 year).
Deaths Number Affected:
6
Deaths Number At Risk:
None
Serious Number Affected:
109
Serious Number At Risk:
698
Other Number Affected:
462
Other Number At Risk:
698
Study:
NCT05665595
Results Section:
NCT05665595
Adverse Events Module:
NCT05665595